Articles with "complement blockade" as a keyword



Photo from wikipedia

Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series

Sign Up to like & get
recommendations!
Published in 2022 at "American Journal of Reproductive Immunology"

DOI: 10.1111/aji.13559

Abstract: We evaluated eculizumab, a complement protein C5 inhibitor, for treatment of severe COVID‐19 in pregnant and postpartum individuals. read more here.

Keywords: eculizumab treatment; complement; blockade eculizumab; complement blockade ... See more keywords
Photo from wikipedia

Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation

Sign Up to like & get
recommendations!
Published in 2020 at "American Journal of Transplantation"

DOI: 10.1111/ajt.15777

Abstract: Delayed graft function (DGF) in renal transplant is associated with reduced graft survival and increased immunogenicity. The complement‐driven inflammatory response after brain death (BD) and posttransplant reperfusion injury play significant roles in the pathogenesis of… read more here.

Keywords: graft; complement; transplantation; function ... See more keywords
Photo by martindorsch from unsplash

Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab.

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood.2019004218

Abstract: Overactivated complement is a high-risk feature in HSCT recipients with transplant associated thrombotic microangiopathy (TA-TMA), and untreated patients have dismal outcomes. We present our experience of 64 pediatric HSCT recipients with high risk TA-TMA and… read more here.

Keywords: high risk; hsct; eculizumab; tma ... See more keywords